COX-2 mRNA analysis determined by qPCR corroborated these findings (Figure 6E), indicating that selective small molecule-based inhibition of HuR functionally impacts tumor COX-2 levels and alters tumor growth potential. This evidence concerns the gene PTGS2 and neoplasm.